Back to top
more

Stryker (SYK)

(Delayed Data from NYSE)

$369.02 USD

369.02
1,366,185

-0.84 (-0.23%)

Updated Nov 6, 2024 04:00 PM ET

After-Market: $369.15 +0.13 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (89 out of 251)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Boston Scientific Stock Gains From Market Expansion, Innovation

by Zacks Equity Research

BSX's Endoscopy business within MedSurg is gaining from strong worldwide demand for its broad range of gastrointestinal and pulmonary treatment options.

Stryker Stock Gains on Q3 Earnings Beat & Raised Guidance

by Zacks Equity Research

SYK's third-quarter results reflect strong segmental performance, along with a rise in operating margin.

Here's What Key Metrics Tell Us About Stryker (SYK) Q3 Earnings

by Zacks Equity Research

Although the revenue and EPS for Stryker (SYK) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Stryker (SYK) Surpasses Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Stryker (SYK) delivered earnings and revenue surprises of 3.24% and 2.31%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Strong Segmental Performance to Drive Stryker's Q3 Earnings

by Zacks Equity Research

SYK's third-quarter 2024 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.

Insights Into Stryker (SYK) Q3: Wall Street Projections for Key Metrics

by Zacks Equity Research

Evaluate the expected performance of Stryker (SYK) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

PBH or SYK: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

PBH vs. SYK: Which Stock Is the Better Value Option?

GE HealthCare Acquires Intelligent Ultrasound's Clinical AI Business

by Zacks Equity Research

GEHC acquires clinical AI business to aid its ultrasound portfolio with AI-driven image analysis tools.

SNN Boosts Knee Revision Surgery With Its LEGION Hinged Knee System

by Zacks Equity Research

Smith & Nephew introduces the LEGION Hinged Knee System with OXINIUM Technology, elevating knee revision surgery through innovation.

Globus Medical Expands Orthopedic Trauma Portfolio With New Launches

by Zacks Equity Research

GMED launches ANTHEM II Distal Radius Volar Plates, AUTOBAHN Trochanteric Nail PRO Instruments and CAPTIVATE SOLA Headless Screws.

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

by Zacks Equity Research

Sector ETF report for IHI

PBH vs. SYK: Which Stock Is the Better Value Option?

by Zacks Equity Research

PBH vs. SYK: Which Stock Is the Better Value Option?

Stryker Stock Gains 18.6% YTD: What's Driving its Share Price?

by Zacks Equity Research

Styker's flagship, Mako Total Knee Platform, its strategic acquisitions and a diversified product portfolio raise optimism about the stock.

SYK Stock May Gain From Completion of Vertos Medical Acquisition

by Zacks Equity Research

Stryker completes the acquisition of Vertos Medical to expand its interventional pain management solutions.

Reasons to Retain Stryker Stock in Your Portfolio for Now

by Zacks Equity Research

SYK continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.

Stryker Shares May Gain on the Completion of the Acquisition of NICO

by Zacks Equity Research

SYK completes the acquisition of NICO to strengthen its portfolio of solutions for tumor resection and the treatment of ICH.

PBH or SYK: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

PBH vs. SYK: Which Stock Is the Better Value Option?

Stryker Stock Declines Despite Completion of care.ai Acquisition

by Zacks Equity Research

SYK completes the acquisition of care.ai, adding AI-based workflows and smart room technology to its portfolio to overcome nursing shortages, and improve staff retention and workplace safety.

Here's How Much a $1000 Investment in Stryker Made 10 Years Ago Would Be Worth Today

by Zacks Equity Research

Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

SYK Stocks Gains Following Expansion of Foot & Ankle Portfolio

by Zacks Equity Research

Stryker unveils two new products, enhancing precision and outcomes in foot and ankle surgeries.

PBH or SYK: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

PBH vs. SYK: Which Stock Is the Better Value Option?

Why Is Stryker (SYK) Up 8.8% Since Last Earnings Report?

by Zacks Equity Research

Stryker (SYK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Stryker Rallies 19.8% Year to Date: What's Driving the Stock?

by Zacks Equity Research

SYK's flagship Mako Total Knee Platform, its strategic acquisitions and a diversified product portfolio raise optimism about the stock.

If You Invested $1000 in Stryker a Decade Ago, This is How Much It'd Be Worth Now

by Zacks Equity Research

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

The Zacks Analyst Blog Toyota Motor, IBM, Stryker and Fossil Group

by Zacks Equity Research

Toyota Motor, IBM, Stryker and Fossil Group are included in this Analyst Blog.